Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ViaLogy selected by Cisco

1 Apr 2008 13:00

ViaLogy PLC01 April 2008 ViaLogy Technology Integrated into New Cisco Open Platform for Safety and Security London, 1 April 2008: ViaLogy PLC (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms, announces its technology is beingintegrated into the Cisco Open Platform for Safety and Security (COPSS), the newCisco technology platform launched today at the annual FOSE 2008 industry tradeshow. The Cisco Open Platform for Safety and Security is a secure, intelligent,converged solution intended for multiple surveillance and alert applications tosupport the growing needs of defence, civilian, public safety, state and localgovernment agencies. It is to be offered by Cisco to public sector organizationson a worldwide basis. As a core member of the solution team, ViaLogy will provide the sensorintegration engine for the platform. ViaLogy's SPMTM (Sensor Policy Manager)software enables disparate sensors in very large enterprise networks to processand report only key events of interest to security personnel. The ViaLogytechnology is sensor agnostic and considerably enhances the performance andstrength of all integrated legacy and IP sensors, thus avoiding false alarms,missed events and optimizing use of limited bandwidth. ViaLogy's SPMTM is anintegral part of the Cisco Open Platform for Safety and Security demonstration -and available for viewing - at Cisco's Center of Excellence in Herndon,Virginia. "We are pleased to be working with Vialogy as part of our go-to-market team forthe Cisco Open Platform for Safety and Security," said Bruce Klein, Cisco'sfederal vice president. "Our strategy is to pull together an 'ecosystem' of theleading companies with expertise in protecting citizens, employees and criticalassets to provide the most comprehensive solution for facilitating collaborationfor government agencies. Vialogy delivers a critical piece of our overalltechnology platform." "Cisco has developed the Cisco Open Platform for Safety and Security to answer aworldwide requirement from customers for improved and co-ordinated integratedsafety and security systems," said Robert W. Dean. President and CEO of ViaLogy,"We are proud to be chosen as an approved supplier to the platform." "SPMTM is a comprehensive and flexible product that can be customised to suitindividual customer needs because we recognise that there are a variety ofsituations to be dealt with. Some customers will want a complete system forsecuring or monitoring a new building or area, others will want the overallintegration of existing and new security arrangements. "The Cisco Open Platform for Safety and Security will give common operationalpicture vigilance of all aspects of security, faster situation assessment,automated decision making and improved response time." ViaLogy has been closely involved in the development of an Improved DecisionSupport System for disparate sensors. As the Department of Defense drivesconvergence of physical security, consequence management and Chemical,Biological, Radiological/Nuclear, and Explosive (CBRNE) incidents to ensuresafety of military bases, scaleable network-centric technologies and IT productsare becoming increasingly important. ViaLogy has demonstrated its successes overthe past year during multiple Department of Defense demonstrations thatcontinually monitored and reported on CBRNE sensors in realistic scenarios.ViaLogy's SPMTM technology flawlessly linked all critical sensors to enableautomatic time alerts to the right person. This sensor integration andinteroperability capability will be a critical factor in next generationnetworked emergency alert systems. To find out more about the Cisco Open Platform for Safety and Security andViaLogy's participation please visit www.vialogy.com. ends Further information from: ViaLogy Robert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defence and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.